XENE
Xenon Pharmaceuticals Inc.
$37.75−1.03 (−2.66%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Nov 5, 2014 – Nov 18, 2026, Dividends reinvested
- Final balance
- $35,952
- CAGR
- +11.22%
- Max drawdown
- −90.43%
Trailing returns (%)
XENE's average annual return was 16.43% over the last 10 years, through Nov 18, 2026. $10,000 in XENE on Nov 18, 2016 grew to $45,758 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +12.72%
- 3M
- −40.25%
- 6M
- −29.72%
- YTD
- −15.77%
- 1Y
- −7.04%
Per year
- 3Y
- +8.64%
- 5Y
- +5.21%
- 10Y
- +16.43%
- Since 2014
- +11.22%
Annual returns
2014 from Nov 5 · 2026 through Nov 18
XENE returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −15.77% |
| 2025 | +14.34% |
| 2024 | −14.89% |
| 2023 | +16.81% |
| 2022 | +26.22% |
| 2021 | +103.12% |
| 2020 | +17.32% |
| 2019 | +107.77% |
| 2018 | +123.36% |
| 2017 | −63.31% |
| 2016 | −4.23% |
| 2015 | −59.29% |
| 2014 from Nov 5 | +88.10% |
Metrics
Since 2014| Volatility | 66.15% |
|---|---|
| Sharpe ratio | 0.47 |
| Sortino ratio | 0.78 |
| Calmar ratio | 0.12 |
| Longest drawdown | 6.7 years |
Worst drawdowns
Since 2014| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −90.4% | Jan 2015 | Nov 2017 | Oct 2021 | 6.7 years |
| −52.8% | Jul 2026 | Oct 2026 | Not yet | 4 months so far |
| −43.6% | Feb 2024 | Apr 2025 | Mar 2026 | 2.1 years |
| −34.1% | May 2023 | Nov 2023 | Dec 2023 | 7 months |
| −30.1% | Nov 2021 | Dec 2021 | Aug 2022 | 9 months |